Tecovirimat treatment for orthopox virus exposure
Part of Infections clinical trials.
This trial tests if tecovirimat can help people exposed to orthopox viruses (like smallpox or monkeypox) or those with serious side effects from the smallpox vaccine. It is for military-affiliated personnel who can swallow pills and be followed for a while.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military-affiliated person (including civilians, contractors, dependents, or allied military) of any age and not breastfeeding.
- You have been exposed to or infected with an orthopox virus (smallpox, monkeypox, cowpox, or vaccinia) or have had severe complications from a smallpox vaccine.
- You are available for the full treatment and follow-up period.
- You can swallow capsules.
- You do not have an allergy to tecovirimat, and you agree to follow the treatment plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for mpox (monkeypox) in people with active sores. It aims to see if the treatment helps clear the infection faster and reduce symptoms.
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
Hear when a new Smallpox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.